Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters










Publication year range
1.
Oral Oncol ; 66: 1-8, 2017 03.
Article in English | MEDLINE | ID: mdl-28249642

ABSTRACT

OBJECTIVES: Establishing adequate resection margins and lymphatic mapping are crucial for the prognosis of oral cancer patients. Novel targeted imaging modalities are needed, enabling pre- and intraoperative detection of tumour cells, in combination with improved post-surgical examination by the pathologist. The urokinase-receptor (uPAR) is overexpressed in head and neck cancer, where it is associated with tumour progression and metastasis. MATERIAL AND METHODS: To determine suitability of uPAR for molecular imaging of oral cancer surgery, human head and neck tumours were sectioned and stained for uPAR to evaluate the expression pattern compared to normal mucosa. Furthermore, metastatic oral squamous carcinoma cell line OSC-19 was used for targeting uPAR in in vivo mouse models. Using anti-uPAR antibody ATN-658, equipped with a multimodal label, the in vivo specificity was investigated and the optimal dose and time-window were evaluated. RESULTS: All human oral cancer tissues expressed uPAR in epithelial and stromal cells. Hybrid ATN-658 clearly visualized tongue tumours in mice using either NIRF or SPECT imaging. Mean fluorescent TBRs over time were 4.3±0.7 with the specific tracer versus 1.7±0.1 with a control antibody. A significant difference in TBRs could be seen between 1nmol (150µg) and 0.34nmol (50µg) dose groups (n=4, p<0.05). Co-expression between BLI, GFP and the NIR fluorescent signals were seen in the tongue tumour, whereas human cytokeratin staining confirmed presence of malignant cells in the positive cervical lymph nodes. CONCLUSION: This study shows the applicability of an uPAR specific multimodal tracer in an oral cancer model, combining SPECT with intraoperative guidance.


Subject(s)
Mouth Neoplasms/diagnostic imaging , Urokinase-Type Plasminogen Activator/metabolism , Animals , Female , Humans , Mice , Mice, Inbred BALB C , Mouth Neoplasms/enzymology , Multimodal Imaging
2.
BMC Cancer ; 16(1): 884, 2016 11 14.
Article in English | MEDLINE | ID: mdl-27842504

ABSTRACT

BACKGROUND: Evaluation of resection margins during cancer surgery can be challenging, often resulting in incomplete tumour removal. Fluorescence-guided surgery (FGS) aims to aid the surgeon to visualize tumours and resection margins during surgery. FGS relies on a clinically applicable imaging system in combination with a specific tumour-targeting contrast agent. In this study EpCAM (epithelial cell adhesion molecule) is evaluated as target for FGS in combination with the novel Artemis imaging system. METHODS: The NIR fluorophore IRDye800CW was conjugated to the well-established EpCAM specific monoclonal antibody 323/A3 and an isotype IgG1 as control. The anti-EpCAM/800CW conjugate was stable in serum and showed preserved binding capacity as evaluated on EpCAM positive and negative cell lines, using flow cytometry and cell-based plate assays. Four clinically relevant orthotopic tumour models, i.e. colorectal cancer, breast cancer, head and neck cancer, and peritonitis carcinomatosa, were used to evaluate the performance of the anti-EpCAM agent with the clinically validated Artemis imaging system. The Pearl Impulse small animal imaging system was used as reference. The specificity of the NIRF signal was confirmed using bioluminescence imaging and green-fluorescent protein. RESULTS: All tumour types could clearly be delineated and resected 72 h after injection of the imaging agent. Using NIRF imaging millimetre sized tumour nodules were detected that were invisible for the naked eye. Fluorescence microscopy demonstrated the distribution and tumour specificity of the anti-EpCAM agent. CONCLUSIONS: This study shows the potential of an EpCAM specific NIR-fluorescent agent in combination with a clinically validated intraoperative imaging system to visualize various tumours during surgery.


Subject(s)
Biomarkers, Tumor , Epithelial Cell Adhesion Molecule/metabolism , Neoplasms/metabolism , Animals , Cell Line, Tumor , Disease Models, Animal , Epithelial Cell Adhesion Molecule/genetics , Female , Gene Expression , Humans , Immunohistochemistry , Mice , Microscopy, Fluorescence , Molecular Imaging , Neoplasms/diagnosis , Neoplasms/surgery , Spectroscopy, Near-Infrared , Surgery, Computer-Assisted , Tumor Burden
3.
Connect Tissue Res ; 56(2): 153-60, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25689091

ABSTRACT

Joints consist of different tissues, such as bone, cartilage and synovium, which are at risk for multiple diseases. The current imaging modalities, such as magnetic resonance imaging, Doppler ultrasound, X-ray, computed tomography and arthroscopy, lack the ability to detect disease activity before the onset of anatomical and significant irreversible damage. Optical in vivo imaging has recently been introduced as a novel imaging tool to study the joint and has the potential to image all kinds of biological processes. This tool is already exploited in (pre)clinical studies of rheumatoid arthritis, osteoarthritis and cancer. The technique uses fluorescent dyes conjugated to targeting moieties that recognize biomarkers of the disease. This review will focus on these new imaging techniques and especially where Near Infrared (NIR) fluorescence imaging has been used to visualize diseases of the joint. NIR fluorescent imaging is a promising technique which will soon complement established radiological, ultrasound and MRI imaging in the clinical management of patients with respect to early disease detection, monitoring and improved intervention.


Subject(s)
Arthritis, Rheumatoid/pathology , Bone and Bones/pathology , Joints/pathology , Osteoarthritis/pathology , Animals , Arthritis, Rheumatoid/diagnosis , Early Diagnosis , Humans , Magnetic Resonance Imaging/methods , Spectroscopy, Near-Infrared
4.
Mol Imaging Biol ; 17(3): 413-23, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25344146

ABSTRACT

PURPOSE: Near-infrared (NIR) fluorescence imaging can provide the surgeon with real-time visualization of, e.g., tumor margins and lymph nodes. We describe and evaluate the Artemis, a novel, handheld NIR fluorescence camera. PROCEDURES: We evaluated minimal detectable cell numbers (FaDu-luc2, 7D12-IRDye 800CW), preclinical intraoperative detection of sentinel lymph nodes (SLN) using indocyanine green (ICG), and of orthotopic tongue tumors using 7D12-800CW. Results were compared with the Pearl imager. Clinically, three patients with liver metastases were imaged using ICG. RESULTS: Minimum detectable cell counts for Artemis and Pearl were 2 × 10(5) and 4 × 10(4) cells, respectively. In vivo, seven SLNs were detected in four mice with both cameras. Orthotopic OSC-19-luc2-cGFP tongue tumors were clearly identifiable, and a minimum FaDu-luc2 tumor size of 1 mm(3) could be identified. Six human malignant lesions were identified during three liver surgery procedures. CONCLUSIONS: Based on this study, the Artemis system has demonstrated its utility in fluorescence-guided cancer surgery.


Subject(s)
Spectroscopy, Near-Infrared/instrumentation , Tongue Neoplasms/pathology , Animals , Calibration , Cell Line, Tumor , Equipment Design , Female , Green Fluorescent Proteins/chemistry , Humans , Indocyanine Green/chemistry , Liver Neoplasms/pathology , Lymph Nodes/pathology , Mice , Mice, Inbred BALB C , Mice, Nude , Microscopy, Fluorescence , Neoplasm Metastasis , Sentinel Lymph Node Biopsy , Signal-To-Noise Ratio
5.
Int J Cancer ; 134(11): 2663-73, 2014 Jun 01.
Article in English | MEDLINE | ID: mdl-24222574

ABSTRACT

Intraoperative near-infrared (NIR) fluorescence imaging is a technology with high potential to provide the surgeon with real-time visualization of tumors during surgery. Our study explores the feasibility for clinical translation of an epidermal growth factor receptor (EGFR)-targeting nanobody for intraoperative imaging and resection of orthotopic tongue tumors and cervical lymph node metastases. The anti-EGFR nanobody 7D12 and the negative control nanobody R2 were conjugated to the NIR fluorophore IRDye800CW (7D12-800CW and R2-800CW). Orthotopic tongue tumors were induced in nude mice using the OSC-19-luc2-cGFP cell line. Tumor-bearing mice were injected with 25 µg 7D12-800CW, R2-800CW or 11 µg 800CW. Subsequently, other mice were injected with 50 or 75 µg of 7D12-800CW. The FLARE imaging system and the IVIS spectrum were used to identify, delineate and resect the primary tumor and cervical lymph node metastases. All tumors could be clearly identified using 7D12-800CW. A significantly higher tumor-to-background ratio (TBR) was observed in mice injected with 7D12-800CW compared to mice injected with R2-800CW and 800CW. The highest average TBR (2.00 ± 0.34 and 2.72 ± 0.17 for FLARE and IVIS spectrum, respectively) was observed 24 hr after administration of the EGFR-specific nanobody. After injection of 75 µg 7D12-800CW cervical lymph node metastases could be clearly detected. Orthotopic tongue tumors and cervical lymph node metastases in a mouse model were clearly identified intraoperatively using a recently developed fluorescent EGFR-targeting nanobody. Translation of this approach to the clinic would potentially improve the rate of radical surgical resections.


Subject(s)
Antibodies, Monoclonal, Humanized/pharmacology , ErbB Receptors/antagonists & inhibitors , Fluorescent Dyes , Head and Neck Neoplasms/pathology , Lymph Nodes/pathology , Nanoparticles/chemistry , Tongue Neoplasms/pathology , Animals , Antibodies, Monoclonal, Humanized/immunology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , ErbB Receptors/immunology , ErbB Receptors/metabolism , Female , Head and Neck Neoplasms/surgery , Humans , Image Processing, Computer-Assisted , Intraoperative Care , Lymph Nodes/surgery , Lymphatic Metastasis , Mice , Mice, Inbred BALB C , Mice, Nude , Microscopy, Fluorescence , Tongue Neoplasms/surgery , Tumor Cells, Cultured
6.
Mol Imaging Biol ; 16(2): 147-51, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24249642

ABSTRACT

During the European Molecular Imaging Meeting (EMIM) 2013, the fluorescence-guided surgery study group held its inaugural session to discuss the clinical implementation of fluorescence-guided surgery. The general aim of this study group is to discuss and identify the steps required to successfully and safely bring intraoperative fluorescence imaging to the clinics. The focus group intends to use synergies between interested groups as a tool to address regulatory and implementation hurdles in Europe and operates within the intraoperative focus group of the World Molecular Imaging Society (WMIS) that promotes the same interests at the WMIS level. The major topics on the critical path of implementation identified within the study group were quality controls and standards for ensuring accurate imaging and the ability to compare results from different studies, regulatory affairs, and strategies to increase awareness among physicians, regulators, insurance companies, and a broader audience. These hurdles, and the possible actions discussed to overcome them, are summarized in this report. Furthermore, a number of recommendations for the future shape of the fluorescence-guided study group are discussed. A main driving conclusion remains that intraoperative imaging has great clinical potential and that many of the solutions required are best addressed with the community working together to optimally promote and accelerate the clinical implementation of fluorescence imaging towards improving surgical procedures.


Subject(s)
Surgical Procedures, Operative/methods , Diagnostic Imaging , Europe , Fluorescence , Health Knowledge, Attitudes, Practice , Humans , Molecular Imaging , Photography/instrumentation , Practice Patterns, Physicians' , Quality Control , Reference Standards , Societies, Medical , Surgical Procedures, Operative/ethics , Surgical Procedures, Operative/legislation & jurisprudence
7.
Biomed Opt Express ; 4(5): 696-708, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23667786

ABSTRACT

Multi diameter single fiber reflectance (MDSFR) spectroscopy is a non-invasive optical technique based on using multiple fibers of different diameters to determine both the reduced scattering coefficient (µs') and a parameter γ that is related to the angular distribution of scattering, where γ = (1-g2)/(1-g1) and g1 and g2 the first and second moment of the phase function, respectively. Here we present the first in vivo MDSFR measurements of µs'(λ) and γ(λ) and their wavelength dependence. MDSFR is performed on nineteen mice in four tissue types including skin, liver, normal tongue and in an orthotopic oral squamous cell carcinoma. The wavelength-dependent slope of µs'(λ) (scattering power) is significantly higher for tongue and skin than for oral cancer and liver. The reduced scattering coefficient at 800 nm of oral cancer is significantly higher than of normal tongue and liver. Gamma generally increases with increasing wavelength; for tumor it increases monotonically with wavelength, while for skin, liver and tongue γ(λ) reaches a plateau or even decreases for longer wavelengths. The mean γ(λ) in the wavelength range 400-850 nm is highest for liver (1.87 ± 0.07) and lowest for skin (1.37 ± 0.14). Gamma of tumor and normal tongue falls in between these values where tumor exhibits a higher average γ(λ) (1.72 ± 0.09) than normal tongue (1.58 ± 0.07). This study shows the potential of using light scattering spectroscopy to optically characterize tissue in vivo.

8.
Cell Death Dis ; 4: e473, 2013 Jan 24.
Article in English | MEDLINE | ID: mdl-23348587

ABSTRACT

Traumatic brain injury is a major public health concern and is characterised by both apoptotic and necrotic cell death in the lesion. Anatomical imaging is usually used to assess traumatic brain injuries and there is a need for imaging modalities that provide complementary cellular information. We sought to non-invasively image cell death in a mouse model of traumatic brain injury using a near-infrared fluorescent conjugate of a synthetic heat shock protein-90 alkylator, 4-(N-(S-glutathionylacetyl) amino) phenylarsonous acid (GSAO). GSAO labels both apoptotic and necrotic cells coincident with loss of plasma membrane integrity. The optical GSAO specifically labelled apoptotic and necrotic cells in culture and did not accumulate in healthy organs or tissues in the living mouse body. The conjugate is a very effective imager of cell death in brain lesions. The optical GSAO was detected by fluorescence intensity and GSAO bound to dying/dead cells was detected from prolongation of the fluorescence lifetime. An optimal signal-to-background ratio was achieved as early as 3 h after injection of the probe and the signal intensity positively correlated with both lesion size and probe concentration. This optical GSAO offers a convenient and robust means to non-invasively image apoptotic and necrotic cell death in brain and other lesions.


Subject(s)
Apoptosis , Arsenicals/chemistry , Brain Injuries/diagnosis , Glutathione/analogs & derivatives , HSP90 Heat-Shock Proteins/chemistry , Alkylation , Animals , Arsenicals/pharmacology , Brain Injuries/metabolism , Brain Injuries/pathology , Cell Line, Tumor , Disease Models, Animal , Fluorescent Dyes/chemistry , Fluorescent Dyes/pharmacology , Glutathione/chemistry , Glutathione/pharmacology , HSP90 Heat-Shock Proteins/metabolism , Humans , Jurkat Cells , Mice , Spectroscopy, Near-Infrared
9.
Head Neck ; 34(1): 120-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21284051

ABSTRACT

A key aspect for the postoperative prognosis of patients with head and neck cancer is complete tumor resection. In current practice, the intraoperative assessment of the tumor-free margin is dependent on visual appearance and palpation of the tumor. Optical imaging has the potential of traversing the gap between radiology and surgery by providing real-time visualization of the tumor, thereby allowing for image-guided surgery. The use of the near-infrared light spectrum offers 2 essential advantages: increased tissue penetration of light and an increased signal-to-background ratio of contrast agents. In this review, the current practice and limitations of image-guided surgery by optical imaging using intrinsic fluorescence or contrast agents are described. Furthermore, we provide an overview of the various molecular contrast agents targeting specific hallmarks of cancer that have been used in other fields of oncologic surgery, and we describe perspectives on its future use in head and neck cancer surgery.


Subject(s)
Head and Neck Neoplasms/surgery , Surgery, Computer-Assisted/methods , Contrast Media , Fluorescence , Forecasting , Head and Neck Neoplasms/diagnosis , Humans , Surgery, Computer-Assisted/trends
10.
Osteoarthritis Cartilage ; 19(11): 1363-72, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21911068

ABSTRACT

OBJECTIVE: In the past years, the canonical Wnt/ß-catenin signaling pathway has emerged as a critical regulator of cartilage development and homeostasis. In this pathway, glycogen synthase kinase-3ß (GSK3ß) down-regulates transduction of the canonical Wnt signal by promoting degradation of ß-catenin. In this study we wanted to further investigate the role of Gsk3ß in cartilage maintenance. DESIGN: Therefore, we have treated chondrocytes ex vivo and in vivo with GIN, a selective GSK3ß inhibitor. RESULTS: In E17.5 fetal mouse metatarsals, GIN treatment resulted in loss of expression of cartilage markers and decreased chondrocyte proliferation from day 1 onward. Late (3 days) effects of GIN included cartilage matrix degradation and increased apoptosis. Prolonged (7 days) GIN treatment resulted in resorption of the metatarsal. These changes were confirmed by microarray analysis showing a decrease in expression of typical chondrocyte markers and induction of expression of proteinases involved in cartilage matrix degradation. An intra-articular injection of GIN in rat knee joints induced nuclear accumulation of ß-catenin in chondrocytes 72 h later. Three intra-articular GIN injections with a 2 days interval were associated with surface fibrillation, a decrease in glycosaminoglycan expression and chondrocyte hypocellularity 6 weeks later. CONCLUSIONS: These results suggest that, by down-regulating ß-catenin, Gsk3ß preserves the chondrocytic phenotype, and is involved in maintenance of the cartilage extracellular matrix. Short term ß-catenin up-regulation in cartilage secondary to Gsk3ß inhibition may be sufficient to induce osteoarthritis-like features in vivo.


Subject(s)
Cartilage, Articular/metabolism , Chondrocytes/metabolism , Glycogen Synthase Kinase 3/physiology , Animals , Biomarkers/metabolism , Extracellular Matrix/metabolism , Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3 beta , Glycosaminoglycans/metabolism , Hindlimb , Mice , Peptide Hydrolases/metabolism , Protein Array Analysis , Rats , Wnt Signaling Pathway/drug effects , beta Catenin/metabolism
11.
Bone ; 49(6): 1264-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21945738

ABSTRACT

Quantification of osteolytic lesions in bone is pivotal in the research of metastatic bone disease in small animal models. Osteolytic lesions are quantified using 2D X-ray photographs, which often neglects to take into account any changes in 3D structure. Furthermore, measurement errors are inadvertently introduced when a region of interest with predefined dimensions is used during MicroCT analysis. To study osteolytic processes, a normalized method of selecting a region of interest is required. Here we describe a new method to select volumes of interest in a normalized way regardless of curvature, fractures or dislocations within the bone. In addition, this method enables the user to visualize normalized cross sections in an exact 90° angle or along the longitudinal axis of bone, at any given point. As a result, the user can compare measurements of diameter, volume and structure between different bones in a normalized manner.


Subject(s)
Bone and Bones/diagnostic imaging , Bone and Bones/pathology , Image Processing, Computer-Assisted/methods , X-Ray Microtomography/methods , Animals , Cell Line, Tumor , Female , Humans , Mice , Mice, Inbred BALB C , Organ Size , Osteolysis/diagnostic imaging , Osteolysis/pathology
12.
Eur Surg Res ; 47(2): 90-7, 2011.
Article in English | MEDLINE | ID: mdl-21720166

ABSTRACT

BACKGROUND: Intraoperative visualization of pancreatic tumors has the potential to improve radical resection rates. Intraoperative visualization of the common bile duct and bile duct anastomoses could be of added value. In this study, we explored the use of indocyanine green (ICG) for these applications and attempted to optimize injection timing and dose. METHODS: Eight patients undergoing a pancreaticoduodenectomy were injected intravenously with 5 or 10 mg ICG. During and after injection, the pancreas, tumor, common bile duct and surrounding organs were imaged in real time using the Mini-FLARE™ near-infrared (NIR) imaging system. RESULTS: No clear tumor-to-pancreas contrast was observed, except for incidental contrast in 1 patient. The common bile duct was clearly visualized using NIR fluorescence, within 10 min after injection, with a maximal contrast between 30 and 90 min after injection. Patency of biliary anastomoses could be visualized due to biliary excretion of ICG. CONCLUSION: No useful tumor demarcation could be visualized in pancreatic cancer patients after intravenous injection of ICG. However, the common bile duct and biliary anastomoses were clearly visualized during the observation period. Therefore, these imaging strategies could be beneficial during biliary surgery in cases where the surgical anatomy is aberrant or difficult to identify.


Subject(s)
Diagnostic Imaging/methods , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy/methods , Adult , Aged , Anastomosis, Surgical , Common Bile Duct/pathology , Common Bile Duct/surgery , Female , Fluorescent Dyes , Humans , Indocyanine Green , Infrared Rays , Intraoperative Period , Male , Middle Aged , Pancreatic Neoplasms/pathology
13.
Eur J Surg Oncol ; 37(3): 252-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21215590

ABSTRACT

AIM: Near-infrared (NIR) fluorescence optical imaging is a promising technique to assess the extent of colorectal metastases during curative-intended surgery. However, NIR fluorescence imaging of liver metastases is highly challenging due to hepatic uptake and clearance of many fluorescent dyes. In the current study, the biodistribution and the ability to demarcate liver and peritoneal metastases were assessed during surgery in a syngeneic rat model of colorectal cancer using an integrin α(v)ß(3)-directed NIR fluorescence probe. METHODS: Liver tumors and peritoneal metastases were induced in 7 male WAG/Rij rats by subcapsular inoculation of 0.5 × 10(6) CC531 colorectal cancer rat cells into three distinct liver lobes. Intraoperative and ex vivo fluorescence measurements were performed 24 (N = 3 rats, 7 tumors) and 48 h (N = 4 rats, 9 tumors) after intravenous administration of the integrin α(v)ß(3)-directed NIR fluorescence probe. RESULTS: Colorectal metastases had a minimal two-fold higher NIR fluorescence signal than healthy liver tissue and other abdominal organs (p < 0.001). The tumor-to-background ratio was independent of time of imaging (24 h vs. 48 h post-injection; p = 0.31), which facilitates flexible operation planning in future clinical applications. Total fluorescence intensity was significantly correlated with the size of metastases (R(2) = 0.92 for the 24 h group, R(2) = 0.96 for the 48 h group). CONCLUSION: These results demonstrate that colorectal intra-abdominal metastases can be clearly demarcated during surgery using an integrin α(v)ß(3) targeting NIR fluorescence probe. Translating these findings to the clinic will have an excellent potential to substantially improve the quality of cancer surgery.


Subject(s)
Colorectal Neoplasms/metabolism , Colorectal Neoplasms/secondary , Integrin alphaVbeta3/metabolism , Liver Neoplasms/pathology , Spectroscopy, Near-Infrared/methods , Animals , Disease Models, Animal , Image Processing, Computer-Assisted , Intraoperative Period , Male , Neoplasm Transplantation , Rats , Tumor Cells, Cultured
14.
Bone ; 48(1): 106-14, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20688203

ABSTRACT

Optical Imaging has evolved into one of the standard molecular imaging modalities used in pre-clinical cancer research. Bone research however, strongly depends on other imaging modalities such as SPECT, PET, x-ray and µCT. Each imaging modality has its own specific strengths and weaknesses concerning spatial resolution, sensitivity and the possibility to quantify the signal. An increasing number of bone specific optical imaging models and probes have been developed over the past years. This review gives an overview of optical imaging modalities, models and probes that can be used to study skeletal complications of cancer in small laboratory animals.


Subject(s)
Bone Neoplasms/secondary , Diagnostic Imaging/methods , Optics and Photonics/trends , Animals , Bone Neoplasms/diagnostic imaging , Forecasting , Positron-Emission Tomography/methods , Tomography, Emission-Computed, Single-Photon/methods , X-Ray Microtomography/methods , X-Rays
15.
Calcif Tissue Int ; 87(2): 99-107, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20473488

ABSTRACT

In recent years study of rare human bone disorders has led to the identification of important signaling pathways that regulate bone formation. Such diseases include the bone sclerosing dysplasias sclerosteosis and van Buchem disease, which are due to deficiency of sclerostin, a protein secreted by osteocytes that inhibits bone formation by osteoblasts. The restricted expression pattern of sclerostin in the skeleton and the exclusive bone phenotype of good quality of patients with sclerosteosis and van Buchem disease provide the basis for the design of therapeutics that stimulate bone formation. We review here current knowledge of the regulation of the expression and formation of sclerostin, its mechanism of action, and its potential as a bone-building treatment for patients with osteoporosis.


Subject(s)
Bone Morphogenetic Proteins/metabolism , Adaptor Proteins, Signal Transducing , Bone Morphogenetic Proteins/genetics , Bone Morphogenetic Proteins/pharmacology , Craniofacial Abnormalities/metabolism , Craniofacial Abnormalities/therapy , Forecasting , Genetic Markers/genetics , Humans , Hyperostosis/metabolism , Hyperostosis/therapy , Mandible/abnormalities , Mandible/metabolism , Osteoblasts/metabolism , Osteochondrodysplasias , Osteocytes/metabolism , Osteogenesis , Osteosclerosis/metabolism , Osteosclerosis/therapy , Signal Transduction , Skull/abnormalities , Skull/metabolism , Syndactyly/metabolism , Syndactyly/therapy
16.
Angiogenesis ; 13(2): 135-47, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20449766

ABSTRACT

In recent years, molecular imaging gained significant importance in biomedical research. Optical imaging developed into a modality which enables the visualization and quantification of all kinds of cellular processes and cancerous cell growth in small animals. Novel gene reporter mice and cell lines and the development of targeted and cleavable fluorescent "smart" probes form a powerful imaging toolbox. The development of systems collecting tomographic bioluminescence and fluorescence data enabled even more spatial accuracy and more quantitative measurements. Here we describe various bioluminescent and fluorescent gene reporter models and probes that can be used to specifically image and quantify neovascularization or the angiogenic process itself.


Subject(s)
Diagnostic Imaging/methods , Neovascularization, Pathologic/diagnosis , Optical Phenomena , Animals , Fluorescent Dyes/metabolism , Genes, Reporter
17.
Eur J Cancer ; 45 Suppl 1: 391-3, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19775643

ABSTRACT

Whole body optical imaging using bioluminescence or fluorescence is one of the most rapidly emerging technologies to non-invasively follow all kinds of molecular and cellular processes in small animals. Using tomographic approaches it is now also possible to get better quantitative data. Due to its sensitivity and simplicity it is now also widely used in drug development and drug screening. Finally, using near infrared fluorescent probes that have much deeper penetration also opens up new exciting applications such as intra-operative image guided surgery for sentinel lymph node mapping and radical resection of tumours. Recent advances in imaging strategies that reveal cellular and molecular biological events in real-time facilitate our understanding of biological processes occurring in living animals. The development of molecular tags, such as green fluorescent protein (GFP) from the jellyfish Aequorea victoria, red fluorescent proteins (RFP) from the Discosoma species (dsRed2) and luciferase (Luc) from the firefly Photinus pyralis (fLuc) and the sea pansy Renilla (rLuc), has revolutionised research over the past decade, allowing complex biochemical processes to be associated with the functioning of proteins in living cells. Optical technologies, both microscopic and macroscopic, are developing fast. Recent technical advances for imaging weak visible light sources using cooled charged coupled device (CCCD) cameras, peltier cooled detectors and micro-plate channel intensifiers allow detection of photon emission from inside the tissues of small animals. Whole body fluorescent imaging (FLI) and bioluminescent imaging (BLI) are now applied to study cell- and tissue-specific gene promoter activity and also to follow trafficking, differentiation and fate of i.e. GFP or RFP and/or luciferase expressing cells, or biological processes like apoptosis, protein-protein interaction, angiogenesis, proteolysis and gene-transfer. Optical imaging (OI) and optical reporter systems are also very cost-effective and time-efficient and they are particularly well suited for small animal imaging and for in vitro assays to validate different reporter systems.


Subject(s)
Intraoperative Care/methods , Luminescent Agents , Neoplasms/diagnosis , Surgery, Computer-Assisted/methods , Whole Body Imaging/methods , Animals , Imaging, Three-Dimensional , Neoplasms/surgery
18.
J Dent Res ; 88(6): 569-74, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19587164

ABSTRACT

Sclerostin is an inhibitor of bone formation expressed by osteocytes. We hypothesized that sclerostin is expressed by cells of the same origin and also embedded within mineralized matrices. In this study, we analyzed (a) sclerostin expression using immunohistochemistry, (b) whether the genomic defect in individuals with van Buchem disease (VBD) was associated with the absence of sclerostin expression, and (c) whether this was associated with hypercementosis. Sclerostin was expressed by cementocytes in mouse and human teeth and by mineralized hypertrophic chondrocytes in the human growth plate. In individuals with VBD, sclerostin expression was absent or strongly decreased in osteocytes and cementocytes. This was associated with increased bone formation, but no overt changes in cementum thickness. In conclusion, sclerostin is expressed by all 3 terminally differentiated cell types embedded within mineralized matrices: osteocytes, cementocytes, and hypertrophic chondrocytes.


Subject(s)
Bone Morphogenetic Proteins/biosynthesis , Bone Morphogenetic Proteins/deficiency , Osteocytes/metabolism , Osteosclerosis/metabolism , Adaptor Proteins, Signal Transducing , Adolescent , Adult , Animals , Child , Chondrocytes/metabolism , Dental Cementum/metabolism , Female , Genetic Markers , Growth Plate/metabolism , Humans , Jaw Abnormalities/etiology , Male , Malocclusion/etiology , Mice , Middle Aged , Osteosclerosis/complications , Osteosclerosis/diagnostic imaging , Radiography, Panoramic , Tooth Abnormalities/etiology , Young Adult
19.
Breast Cancer Res Treat ; 118(2): 307-13, 2009 Nov.
Article in English | MEDLINE | ID: mdl-18989771

ABSTRACT

Bisphosphonates decrease bone resorption and reduce significantly the rate of skeletal complications in patients with metastatic bone disease. Bisphosphonates have also been shown to exhibit antitumor activity in vitro but in vivo results have been equivocal. In the present study, we investigated the effects of bisphosphonate treatment alone or in combination with the cytostatic docetaxel on the growth of breast cancer cells in bone. Tumor gowth was studied in an athymic nude mice model inoculated with MDA-231-B/luc+ breast cancer cells. Two days after the inoculation, mice were treated with risedronate, zolendronate or docetaxel alone or with a combination of risedronate and docetaxel. Bone destruction and tumor growth were evaluated radiographically, histologically and by whole-body bioiluminescent reporter imaging (BLI). Five week treatment with high doses risedronate or zoledronate (37.5-150 microg/kg, 5 times/week), fully protected the bones from osteolysis, but did not affect tumour growth. Docetaxel (2, 4, and 8 mg/kg, 2 times/week) inhibited tumour growth dose-dependently and after 5 weeks treatment with the highest dose, there was no detectable tumour in bone. The combination of a dose of docetaxel (4 mg/kg) that demonstrated only a minimal effect on tumour growth, with risedronate (150 microg/kg), protected bone integrity and nearly completely inhibited the growth of the cancer cells. Risedronate and docetaxel act synergistically to protect bone and decrease tumour burden in an animal model of established bone metastases from breast cancer cells.


Subject(s)
Antineoplastic Agents/therapeutic use , Bone Density Conservation Agents/therapeutic use , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Diphosphonates/therapeutic use , Taxoids/therapeutic use , Animals , Breast Neoplasms/pathology , Disease Models, Animal , Docetaxel , Drug Synergism , Female , Humans , Mice , Mice, Nude , Neoplasm Metastasis/drug therapy , Xenograft Model Antitumor Assays
20.
J Clin Endocrinol Metab ; 92(3): 1088-95, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17164305

ABSTRACT

CONTEXT: The PTH/PTHrP receptor type 1 (PTHR1) has a key role in endochondral ossification, which is emphasized by diseases resulting from mutations in the PTHR1 gene. Among these diseases is Blomstrand osteochondrodysplasia (BOCD). OBJECTIVE: BOCD can be divided into two types, depending on the severity of the skeletal abnormalities. The molecular basis for this heterogenic presentation is unknown. DESIGN AND PATIENTS: We performed mutation analysis in two families with type I and in three families with the less severe form of BOCD type II. RESULTS: In one of the type I BOCD cases, a homozygous nonsense mutation (R104X) was found, resulting in a truncated PTHR1. In the second type I BOCD case, no mutation was found. A homozygous nucleotide change (intron M4+27C>T) was demonstrated in one of the type II BOCD cases creating a novel splice site. In dermal fibroblasts of the patient, this novel splice site was preferentially used, resulting in an aberrant transcript. The wild-type transcript remained, however, present, albeit at low levels. In the other two families with type II BOCD, a previously identified homozygous missense mutation (P132L) was found. Functional analysis demonstrated that the P132L mutant had low residual activity. CONCLUSIONS: In combination with data presented in literature, we conclude that type I BOCD is caused by a complete inactivation of the PTHR1, whereas low levels of residual activity due to a near complete inactivation of the PTHR1 result in the relatively milder presentation of type II BOCD.


Subject(s)
Mutation , Osteochondrodysplasias/genetics , Parathyroid Hormone/genetics , Receptor, Parathyroid Hormone, Type 1/genetics , Amino Acid Sequence , Animals , Base Sequence , COS Cells , Cells, Cultured , Chlorocebus aethiops , Diagnosis , Humans , Infant, Newborn , Models, Biological , Molecular Sequence Data , Osteochondrodysplasias/diagnosis , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...